Identity
- Trade Name
- Rowley Biochemical Congo Red, 10% Aqueous FDA UDI
- Generic Name
- Biological stain IVD FDA UDI
- Device Name
- Congo Red, 10% Aqueous FDA UDI
- Model / Reference
- 1 FDA UDI
- Description
- Congo Red, 10% Aqueous FDA UDI
Identifiers
- Primary DI / UDI-DI
- SO920852042008 FDA UDI
- FDA Product Code
- ICH FDA UDI
- GMDN Term
- Biological stain IVD FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 864.1850 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Biological stain IVD
Rowley Biochemical Congo Red, 10% Aqueous by Transene Company, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Biological stain IVD.
- REMEL — REMEL, INC. · Class I
- Genemed® — Sakura Finetek USA, Inc · Class I
- Hematek® Stain Pak - Wright-Giemsa Stain — Siemens Healthcare Diagnostics · Class I
- BD BBL™ TB Fluorescent Stain Kit M — BECTON DICKINSON AND COMPANY · Class I
- REMEL — REMEL, INC. · Class I
- REMEL — REMEL, INC. · Class I
- ADVIA® Autoslide Wright Giemsa Stain — Siemens Healthcare Diagnostics · Class I
- Alinity — Abbott · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Transene Company, Inc.
Sources (1)
- FDA UDI ecf7a21e-c655-4498-b607-5720609d82fe 33 fields · synced May 30, 2026